PDB17 TOTAL Cost of Care and Utilization Among Medicare Fee-for-Service (FFS) Patients with Metastatic Pancreatic Cancer Treated with FDA-Approved/NCCN® Category 1 Regimens at 340B VS. NON-340B Hospitals
Abstract
Authors
S. Tomicki H. Latimer G. Dieguez P. Cockrum G.P. Kim